Researcher
Guy Bormans
- Disciplines:Other chemical sciences, Chemical product design and formulation, Biomaterials engineering, Medical imaging and therapy, Medicinal products
Affiliations
- Radiopharmaceutical Research (Division)
Responsible
From1 Oct 2014 → Today - Radiopharmaceutical Research (Division)
Member
From1 Oct 1999 → Today
Projects
1 - 10 of 39
- Research on radioactive nuclei at ISOLDE-CERN, SPIRAL2- GANIL and MEDICIS-CERNFrom1 Jan 2023 → TodayFunding: FWO International research infrastructure (IRI)
- Development of TRNT radiopharmaceuticals targeting Hsp90From1 Oct 2022 → 31 Dec 2023Funding: Own budget, for example: patrimony, inscription fees, gifts
- IMAGINATION : IMAGing bIomarkers for diagNosis, therAnosTIcs and drug develOpmeNtFrom1 Oct 2022 → TodayFunding: IOF - mandates
- Translational investigation of the role of Hsp90 in neurodegenerative proteinopathies using positron emission tomography (PET)From1 Jan 2022 → TodayFunding: FWO research project (including WEAVE projects)
- Targeting radionuclides to tumors expressing extracellular Hsp90 using rationally designed peptide probesFrom22 Jun 2021 → TodayFunding: Own budget, for example: patrimony, inscription fees, gifts
- Peptide based CXCR4 targeting for PET imaging and radionuclide therapyFrom1 Jan 2021 → TodayFunding: Foundations, funds and other with scientific goal
- Unfolding the role of Hsp90 in brain: a multidisciplinary translational approachFrom1 Jun 2020 → 31 May 2022Funding: BOF - various
- Terbium labeling of anti-CEA nanobodies for in vivo imaging and therapy of colorectal cancerFrom1 Jan 2020 → 31 Dec 2020Funding: FWO research grant KAN
- Protein aggregation and folding as target for molecular imaging and radionuclide therapyFrom1 Oct 2019 → 30 Sep 2023Funding: IOF - technology concept exploration
- Click chemistry Options for Live Immuno Brain ImagingFrom1 Oct 2019 → 30 Sep 2021Funding: H2020 - Skills and Career Development (Marie Skłodowska-Curie) actions
Publications
211 - 220 of 286
- Brain type 1 cannabinoid receptor availability in patients with anorexia and bulimia nervosa(2011)
Authors: Guido Pieters, Karolien Goffin, Guy Bormans, Koen Van Laere
Pages: 777 - 784 - A Dual-targeting Anticancer Approach: Soil and Seed Principle(2011)
Authors: Junjie Li, Marlein Miranda Cona, Feng Chen, Lin Zhou, Johan Nuyts, Guy Bormans, Peter de Witte, Alfons Verbruggen, Luc Mortelmans, Guy Marchal, et al.
Pages: 799 - 807 - Radiolabeled Iodohypericin as Tumour Necrosis Avid Tracer - Diagnostic and Therapeutic Potential(2011)
Authors: Guy Bormans, Alfons Verbruggen, Peter de Witte
Pages: S153 - S154 - Synthesis, in vivo occupancy, and radiolabeling of potent phosphodiesterase subtype-10 inhibitors as candidates for positron emission tomography imaging(2011)
Authors: Sofie Celen, Guy Bormans
Pages: 5820 - 35 - Radiosynthesis and biological evaluation of a carbon-11 labelled vardenafil derivative as a PDE5 specific tracer(2011)
Authors: Rufael Chekol, Olivier Gheysens, Jan Cleyhens, Stefan Janssens, Alfons Verbruggen, Guy Bormans
Pages: S152 - S152 - Synthesis, in vitro and in vivo evaluation of fluorine-18 labelled FE-GW405833 as a PET tracer for type 2 cannabinoid receptor imaging(2011)
Authors: Caroline Vandeputte, Veerle Baekelandt, Alfons Verbruggen, Zeger Debyser, Koen Van Laere, Guy Bormans
Pages: 4499 - 4505 - Metabolic and Type 1 cannabinoid receptor imaging of a transgenic rat model in the early phase of Huntington disease(2011)
Authors: Cindy Casteels, Caroline Vandeputte, Janaki Raman Rangarajan, Tom Dresselaers, Guy Bormans, Frederik Maes, Uwe Himmelreich, Koen Van Laere
Pages: 440 - 449 - Different regional brain activity during physiological gastric distension compared to balloon distension: a (H2O)-O-15-PET study(2011)
Authors: Lukas Van Oudenhove, Patrick Dupont, Guy Bormans, Koen Van Laere, Jan Tack
Pages: 533 - E203 - A PET brain reporter gene system based on type 2 cannabinoid receptors(2011)
Authors: Caroline Vandeputte, Jaan Toelen, Christophe Deroose, Rik Gijsbers, Peter Janssen, Alfons Verbruggen, Zeger Debyser, Guy Bormans, Veerle Baekelandt, Koen Van Laere
Pages: 1102 - 1109 - MRK-409 (MK-0343), a GABA(A) receptor subtype-selective partial agonist, is a non-sedating anxiolytic in preclinical species but causes sedation in humans(2011)
Authors: Koen Van Laere, Guy Bormans, Jan de Hoon, Anne Van Hecken
Pages: 314 - 328
Patents
1 - 4 of 4